TY - JOUR
T1 - Healthy Lifestyle Interventions to Combat Noncommunicable Disease - A Novel Nonhierarchical Connectivity Model for Key Stakeholders
T2 - A Policy Statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine
AU - Arena, Ross
AU - Guazzi, Marco
AU - Lianov, Liana
AU - Whitsel, Laurie
AU - Berra, Kathy
AU - Lavie, Carl J.
AU - Kaminsky, Leonard
AU - Williams, Mark
AU - Hivert, Marie France
AU - Franklin, Nina Cherie
AU - Myers, Jonathan
AU - Dengel, Donald
AU - Lloyd-Jones, Donald M.
AU - Pinto, Fausto J.
AU - Cosentino, Francesco
AU - Halle, Martin
AU - Gielen, Stephan
AU - Dendale, Paul
AU - Niebauer, Josef
AU - Pelliccia, Antonio
AU - Giannuzzi, Pantaleo
AU - Corra, Ugo
AU - Piepoli, Massimo F.
AU - Guthrie, George
AU - Shurney, Dexter
N1 - Publisher Copyright:
© 2015 Mayo Foundation for Medical Education and Research and the European Society of Cardiology.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Noncommunicable diseases (NCDs) have become the primary health concern for most countries around the world. Currently, more than 36 million people worldwide die from NCDs each year, accounting for 63% of annual global deaths; most are preventable. The global financial burden of NCDs is staggering, with an estimated 2010 global cost of $6.3 trillion (US dollars) that is projected to increase to $13 trillion by 2030. A number of NCDs share one or more common predisposing risk factors, all related to lifestyle to some degree: (1) cigarette smoking, (2) hypertension, (3) hyperglycemia, (4) dyslipidemia, (5) obesity, (6) physical inactivity, and (7) poor nutrition. In large part, prevention, control, or even reversal of the aforementioned modifiable risk factors are realized through leading a healthy lifestyle (HL). The challenge is how to initiate the global change, not toward increasing documentation of the scope of the problem but toward true action - creating, implementing, and sustaining HL initiatives that will result in positive, measurable changes in the previously defined poor health metrics. To achieve this task, a paradigm shift in how we approach NCD prevention and treatment is required. The goal of this American Heart Association/European Society of Cardiology/European Association for Cardiovascular Prevention and Rehabilitation/American College of Preventive Medicine policy statement is to define key stakeholders and highlight their connectivity with respect to HL initiatives. This policy encourages integrated action by all stakeholders to create the needed paradigm shift and achieve broad adoption of HL behaviors on a global scale.
AB - Noncommunicable diseases (NCDs) have become the primary health concern for most countries around the world. Currently, more than 36 million people worldwide die from NCDs each year, accounting for 63% of annual global deaths; most are preventable. The global financial burden of NCDs is staggering, with an estimated 2010 global cost of $6.3 trillion (US dollars) that is projected to increase to $13 trillion by 2030. A number of NCDs share one or more common predisposing risk factors, all related to lifestyle to some degree: (1) cigarette smoking, (2) hypertension, (3) hyperglycemia, (4) dyslipidemia, (5) obesity, (6) physical inactivity, and (7) poor nutrition. In large part, prevention, control, or even reversal of the aforementioned modifiable risk factors are realized through leading a healthy lifestyle (HL). The challenge is how to initiate the global change, not toward increasing documentation of the scope of the problem but toward true action - creating, implementing, and sustaining HL initiatives that will result in positive, measurable changes in the previously defined poor health metrics. To achieve this task, a paradigm shift in how we approach NCD prevention and treatment is required. The goal of this American Heart Association/European Society of Cardiology/European Association for Cardiovascular Prevention and Rehabilitation/American College of Preventive Medicine policy statement is to define key stakeholders and highlight their connectivity with respect to HL initiatives. This policy encourages integrated action by all stakeholders to create the needed paradigm shift and achieve broad adoption of HL behaviors on a global scale.
UR - http://www.scopus.com/inward/record.url?scp=84938748064&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938748064&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2015.05.001
DO - 10.1016/j.mayocp.2015.05.001
M3 - Review article
C2 - 26143646
AN - SCOPUS:84938748064
SN - 0025-6196
VL - 90
SP - 1082
EP - 1103
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 8
ER -